February 21, 2018 / 10:14 PM / 8 months ago

BRIEF-GW Pharma Says Mid Stage Study Of Seizures Drug Failed Main Goal

Feb 21 (Reuters) - GW Pharmaceuticals Plc:

* GW PHARMACEUTICALS ANNOUNCES PRELIMINARY RESULTS OF PHASE 2A STUDY FOR ITS PIPELINE COMPOUND GWP42006

* GW PHARMA - PHASE 2A PROOF OF CONCEPT STUDY OF A PIPELINE COMPOUND GWP42006 IN ADULT PATIENTS WITH FOCAL SEIZURES DID NOT MEET ITS PRIMARY ENDPOINT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below